[1]
|
Berasain, C., Betés, M., Panizo, A., Ruiz, J., Herrero, J.I., Civeira, M.-P. et al. (2000) Pathological and virological findings in patients with aetiology persistent hyper-transaminasaemia of unknown. Gut, 47, 429-435.
doi:10.1136/gut.47.3.429
|
[2]
|
Diodati, G., Pontisso, P., Bonetti, P., Stenico, D., Noventa, F., Alberti, A., et al. (1988) Cryptogenic chronic liver disease and serum or liver hepatitis B virus markers. Their possible correlations and etiologic significance. Digestion, 39, 251-256. doi:10.1159/000199633
|
[3]
|
Chemin, I., Zoulim, F., Merle, P., Arkhis, A., Chevallier, M., Kay, A., et al. (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown ae-tiology. Journal of Hepatology, 34, 447-454.
doi:10.1016/S0168-8278(00)00100-8
|
[4]
|
Castillo, I., Pardo, M., Bartolome, J., Ortiz-Movilla, N., Rodriguez-Inigo, E., de Lucas, S., et al. (2004) Occult hepatitis C virus infection in patients in whom the etiol-ogy of persistently abnormal results of liver-function tests is unknown. Journal of Infectious Diseases, 189, 7-14. doi:10.1086/380202
|
[5]
|
Abdel-Aziz, F., Habib, M., Mohamed, M.K., Ab-del-Hamid, M., Gamil, F., Madkour, S., et al. (2000) Hepatitis C virus (HCV) infection in a community in the Nile Delta: Population description and HCV prevalence. Hepatology, 32, 111-115. doi:10.1053/jhep.2000.8438
|
[6]
|
Nafeh, M.A., Medhat, A., Shehata, M., Mikhail, N.N., Swifee, Y., Abdel-Hamid, M., et al. (2000) Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. American Journal of Tropical Medicine and Hygiene, 63, 236-241.
|
[7]
|
El-Sadawy, M., Ragab, H., el-Toukhy, H., el-Mor Ael, L., Mangoud, A.M., Eissa, M.H., et al. (2004) Hepatitis C virus infection at Sharkia Governorate, Egypt: Sero-prevalence and associated risk factors. Journal of the Egyptian Society of Parasitology, 34, 367-384.
|
[8]
|
El-Zanaty, F. and Way, A. (2009) Egypt demographic and health survey 2008. Ministry of Health, El-Zanaty and Associates and Macro International.
|
[9]
|
Mezban, Z.D. and Wakil, A.E. (2006) Hepatitis C in Egypt. American Journal of Gastroenterology.
|
[10]
|
Abdel-Hamid, M., Edelman, D.C., Highsmith, W.E., et al. (1997) Optimization, assessment, and proposed use of a direct nested reverse transcribtion-polymease chain reac-tion protocol for the detection of hepatitis C virus. Jour-nal of Human Virology, 1, 58-65.
|
[11]
|
Bedossa, P. and Poynard, T. (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology, 24, 289-293. doi:10.1002/hep.510240201
|
[12]
|
McOmish, F., Yap, P.L., Dow, B.C., Follett, E.A., Seed, C., Keller, A.J., et al. (1994) Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. Journal of Clinical Microbiology, 32, 884-892.
|
[13]
|
Constantine, N.T., Abdel-Hamid, M. and Oldach, D.W. (1995) Rapid genotyping of hepatitis C virus. New Eng-land Journal of Medicine, 333, 800.
doi:10.1056/NEJM199509213331213
|
[14]
|
Frank, C., Mohamed, M.K., Strickland, G.T., Lavanchy, D., Arthur, R.R., Magder, L.S., et al. (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355, 887-891.
doi:10.1016/S0140-6736(99)06527-7
|
[15]
|
Pybus, O.G., Charleston, M.A., Gupta, S., Rambaut, A., Holmes, E.C. and Harvey, P.E. (2001) The epidemic be-haviour of the hepatitis C virus. Science, 292, 2323-2325.
doi:10.1126/science.1058321
|
[16]
|
Tanaka, Y., Shimoike, T., Ishii, K., Suzuki, R., Suzuki, T., Ushijima, H., et al. (2000) Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corre-sponding to the 5’ untranslated region of the viral ge-nome. Virology, 270, 229-236.
doi:10.1006/viro.2000.0252
|
[17]
|
Zakaria, S., Fouad, R., Shaker, O., Zaki, S., Hashem, A., El-Kamary, S.S., et al. (2007) Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clinical Infectious Diseases, 44, 30-36.
doi:10.1086/511074
|
[18]
|
Schmidt, W.N., Wu, P., Cederna, J., Mitros, F.A., LaBrec-que, D.R. and Stapleton, J.T. (1997) Surreptitious hepati-tis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. Journal of Infectious Diseases, 176, 27-33. doi:10.1086/514033
|
[19]
|
Stapleton, J.T., Schmidt, W.N. and Katz, L. (2004) Sero-negative hepatitis C virus infection, not just RNA detec-tion. Journal of Infectious Diseases, 190, 651-652.
doi:10.1086/421282
|
[20]
|
Saleh, A., Yousry, M., Hassan, E.S., et al. (2008) Study of the prevalence of occult Hepatitis C virus infection in patients with persistent hypertransaminasaemia of un-known etiology, and its correlation with hepatic histopa-thological change. Journal of the Egyptian Society of Parasitology.
|
[21]
|
Quiroga, J.A., Castillo, I., Bartolome, J., and Carreno, V. (2007) Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies. Clinical and Vaccine Immunology, 14, 1302- 1306. doi:10.1128/CVI.00128-07
|
[22]
|
Habib, M., Mohamed, M.K., Abdel Aziz, F., Magder, L.S., Abdel Hamid, M., Gamil, F., et al. (2001) Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity. Hepatology, 33, 248-253.
doi:10.1053/jhep.2001.20797
|
[23]
|
Pardo, M., Lo′pez-Alcorocho, J.M., Rodr?′guez-In?igo, E., Castillo, I., and Carren?O, V. (2007) Comparative study between occult hepatitis C virus infection and chronic hepatitis C. Journal of Viral Hepatitis, 14, 36-40.
|
[24]
|
Sanyal, A.J. (2002) AGA technical review on nonalco-holic fatty liver disease. Gastroenterology, 123, 1705- 1725. doi:10.1053/gast.2002.36572
|
[25]
|
Haydon, G.H., Jarvis, L.M., Blair, C.S., Simmonds, P., Harrison, D.J., Simpson, K.J., et al. (1998) Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut, 42, 570-575.
doi:10.1136/gut.42.4.570
|
[26]
|
Sorbi, D., Boynton, J. and Lindor, K.D. (1999) The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steato-hepatitis from alcoholic liver disease. American Journal of Gastroenterology, 94, 1018-1022.
doi:10.1111/j.1572-0241.1999.01006.x
|
[27]
|
Kamal, M.S. and Nasser, A.I. (2008) Hepatitis C geno-type 4. Hepatology, 47, 1371-1383.
doi:10.1002/hep.22127
|
[28]
|
Genovese, D., Dettori, S., Argentini, C., Villano, U., Chionne, P., Angelico, M., et al. (2004) Molecular epi-demiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. Journal of Clinical Microbiology, 43, 1902-1909.
doi:10.1128/JCM.43.4.1902-1909.2005
|
[29]
|
Seki, S., Kitada, T., Yamada, T., et al. (2002) In situ de-tection of lipid peroxidation and oxidative DNA damage in nonalcoholic fatty liver diseases. Journal of Hepatol-ogy, 37, 56-62.
doi:10.1016/S0168-8278(02)00073-9
|
[30]
|
Farrell, G.C. (2003) Nonalcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? Journal of Gastroenterology and Hepatology, 18, 124- 138. doi:10.1046/j.1440-1746.2003.02989.x
|
[31]
|
Brunt, E.M. (2007) Pathology of fatty liver disease. Modern Pathology, 20, 40-48.
doi:10.1038/modpathol.3800680
|